Trial Profile
Post-Marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Phase 4).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2023
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms J-ACT
- Sponsors Mitsubishi Pharma Corporation; Mitsubishi Tanabe Pharma Corporation
- 13 Feb 2009 Actual patient numbers (58) added as reported by ClinicalTrials.gov.
- 13 Feb 2009 Actual patient numbers (58) added as reported by ClinicalTrials.gov.
- 13 Feb 2009 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.